Accurate Wealth Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Accurate Wealth Management’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.8M	Buy	+47,786	New	+$4.31M	0.46%	42
2026 Q1	–	Sell	-75,126	Closed	-$6.37M	–	550
2025 Q4	$6.37M	Buy	+75,126	New	+$6M	0.81%	19
2024 Q2	–	Sell	-116,854	Closed	-$7.36M	–	335
2024 Q1	$7.36M	Buy	+116,854	New	+$7.72M	2.15%	5

Other funds holding IHE

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

IWS

Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

Accurate Wealth Management's IHE Position: Q2 2026 in Review

Accurate Wealth Management opened a new position in iShares US Pharmaceuticals ETF (IHE) in Q2 2026: 47,786 shares worth $4.8M. The stake represents 0.46% of the portfolio and ranks #42 among its holdings. This is a return to the name: Accurate Wealth Management previously reported a position in IHE as recently as Q4 2025.

Accurate Wealth Management first reported a position in IHE in Q1 2024 and has held it in 3 quarters since. The position peaked at $7.36M in Q1 2024. 209 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

Accurate Wealth Management held 47,786 shares of iShares US Pharmaceuticals ETF worth $4.8M as of Q2 2026.
iShares US Pharmaceuticals ETF was a new Accurate Wealth Management position in Q2 2026.
iShares US Pharmaceuticals ETF made up 0.46% of Accurate Wealth Management's portfolio in Q2 2026, its #42 holding.
Accurate Wealth Management first reported a position in iShares US Pharmaceuticals ETF in Q1 2024 and has held it in 3 quarters since.
Accurate Wealth Management's iShares US Pharmaceuticals ETF position peaked at $7.36M in Q1 2024.
209 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on Accurate Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.